Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529923
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529923
Telmisartan Market, By Composition, By Indication, By Dosage Form, By Distribution Channel, By Geography
PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Global telmisartan market is estimated to be valued at USD 4.20 Bn in 2024 and is expected to reach USD 5.41 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 4.20 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 3.70% | 2031 Value Projection: | US$ 5.41 Bn |
Figure. Telmisartan Market Share (%), By Region 2024
Telmisartan is an angiotensin II receptor antagonist that is used primarily in the treatment of hypertension and diabetic nephropathy. It works by selectively blocking the binding of angiotensin II to the AT1 receptors present in vascular smooth muscle and the adrenal glands. By blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II, telmisartan helps lower blood pressure. It is available under various brand names as an oral medication and has a well-established safety profile supported by long-term clinical trials. Growing awareness about cardiovascular health and increasing prevalence of hypertension can drive the global telmisartan market growth.
Market Dynamics:
Global telmisartan market growth is driven by factors such as rapidly aging population, rising prevalence of hypertension worldwide, increasing adoption of sedentary lifestyle resulting in obesity, and growing healthcare expenditure in emerging nations. However, availability of generic substitutes and patent expiration of major brands can pose challenges for market players. Continuous research on expanding therapeutic applications of telmisartan and ongoing clinical trials evaluating its efficacy in treatment of conditions beyond hypertension can offer opportunities for stakeholders in the near future. Partnerships with local distribution networks in developing countries also provide an attractive avenue for leveraging unmet demand.
Key Features of the Study:
- This report provides in-depth analysis of the global telmisartan market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global telmisartan market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include, Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Abbott Laboratories, Cadila Healthcare Ltd, Torrent Pharmaceuticals Ltd., Merck KGaA, Pfizer Inc., Sanofi S.A., Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Macleods Pharmaceuticals Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global telmisartan market
Detailed Segmentation-
- By Composition
- Single
- Combinational
- By Indication
- Hypertension
- Nephropathy
- Hepatorenal Syndrome
- Cardiac Arrest
- Stroke
- By Dosage Form
- Tablets
- Capsules
- Injection
- Oral suspension
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Boehringer Ingelheim GmbH
- Glenmark Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Aurobindo Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- Cipla Ltd.
- Abbott Laboratories
- Cadila Healthcare Ltd
- Torrent Pharmaceuticals Ltd.
- Merck KGaA
- Pfizer Inc.
- Sanofi S.A.
- Bayer AG
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited
- Macleods Pharmaceuticals Ltd.
Product Code: CMI2524
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Composition
- Market Snapshot, By Indication
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Telmisartan Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Telmisartan Market, By Composition, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Single
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Combinational
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Telmisartan Market, By Indication 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hypertension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nephropathy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hepatorenal Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiac Arrest
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Stroke
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Telmisartan Market, By Dosage Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Telmisartan Market, By Distribution Channel 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Telmisartan Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Boehringer Ingelheim GmbH
- Company Highlights
- Composition Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals Ltd.
- Company Highlights
- Composition Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Composition Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sandoz International GmbH
- Company Highlights
- Composition Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aurobindo Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- Cipla Ltd.
- Abbott Laboratories
- Cadila Healthcare Ltd
- Torrent Pharmaceuticals Ltd.
- Merck KGaA
- Pfizer Inc.
- Sanofi S.A.
- Bayer AG
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited
- Macleods Pharmaceuticals Ltd.
- Boehringer Ingelheim GmbH
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.